Skolnick et al., From genes to protein structure and function: novel applications of computational approaches in the genomic era, Jan. 2000, Trends in Biotech. 18(1):34-39.* |
Ngo et al, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.* |
Kuby et al, 1994, Immunology, Second edition, pp. 86-96.* |
Colman et al, 1994, A structural view of immune recognition by antibodies, pp. 33-36.* |
Harlow et al (In Antibodies a Laboratory Manual, 1988, Cold Spring harbor laboratory publication, Cold Spring Harbor, NY, p. 93, pp. 139-149, and 626-629.* |
Abaza et al, J of Protein Chemistry 11(5):433-444, 1992.* |
Hong, Z. et al., “Schistosoma mansoni: Cloning of a Complementary DNA Encoding a Cytosolic Cu/Zn Superoxide Dismutase and High-Yield Expression of the Enzymatically Active Gene Product in Escherichia coli,” Exp. Parasitol. 75:308-322, Academic Press, Inc. (1992). |
Baret, A. et al., in: Oxy Radicals and Their Scavenger Systems, vol. II: Cellular and Medical Aspects, Proc. Third International Conference on Superoxide & Superoxide Dismutase, Greenwald and Cohen, eds., Elsevier Biomedical, New York, NY, pp. 274-280 (1982). |
Baum, J.A. et al., “Isolation and Characterization of the Cystolic and Mitochondrial Superoxide Dismutase of Maize,” Arch. Biochem. Biophys. 20:249-264, Academic Press, Inc. (1981). |
Boissinot, M. et al., “Rational Design and Expression of a Heparin-Targeted Human Superoxide Dismutase,” Biochem. Biophys. Res. Comm. 190:250-256, Academic Press, Inc. (Jan. 1993). |
Burmeister, W.-P. et al., “Sequence and Crystallization of Influenza Virus B/Beijing/1/87 Neuraminidase,” Virology 180:266-272, Academic Press (1991). |
Cannon, R.E. et al., “Two cDNAs encode two nearly identical Cu/Zn Superoxide dismutase proteins in maize,” Mol. Gen. Genet. 219:1-8, Springer-Verlag (1989). |
Church, S.L., “Manganese superoxide dismutase: nucleotide and deduced amino acid sequence of a cDNA encoding a new human transcript,” Biochim. Biophys. Acta. 1087:250-252, a Elsevier Science (1990). |
Cizeski, V. et al., “The Copper Chaperone for Superoxide Dismutase,” J. Biol. Chem. 272:23469-23472, American Society for Biochemistry and Molecular Biology, Inc. (1997). |
Danciger, E. et al., “Human Cu/Zn superoxide dismutase gene family: Molecular structure and characterization of four Cu/Zn superoxide dismutase-related pseudogenes,” Proc. Natl. Acad. Sci. USA 83:3619-3623, National Academy of Sciences (1986). |
Deng, H.-X. et al., “Amyotrophic Lateral Sclerosis and Structural Defects in Cu,Zn Superoxide Dismutase,” Science 261:1047-1051, American Association for the Advancement of Science (Aug. 1993). |
Hagiwara, H. et al., “Recombinant manufacture of human superoxide dismutase (h-SOD) derivatives,” Chem. Abstracts 114:548 abstract No. 60461h, Chemical Abstracts Service (1991). |
Hatanaka, H. et al., “Preparation of superoxide dismutase (SOD) containing heparin-binding site for protease resistance,” Chem. Abstracts 117:375 abstract No. 166676j, Chemical Abstracts Service (1992). |
Houlné, G. and Schantz, R., “Characterization of cDNA sequence for LHC1 apoproteins in Euglena gracilis: The mRNA encodes a large precursor containing several consecutive divergent polypeptides,” Mol. Gen. Genet. 213:479-486, Springer-Verlag (1988). |
Inoue, M. et al., “Long chain carboxylic acid maleimides for modification of superoxide dismutase,” Chem. Abstracts 118:309 Abstract No. 18538w, Chemical Abstracts Service (Jan. 1993). |
Katsukura, Y. and H. Ochi, “Superoxide dismutase, its manufacture with Streptococcus and therapeutic use,” Chem. Abstracts 107:633 Abstract No. 234823a, Chemical Abstracts Service (1987). |
Kong, X.-J. et al., “Cu, Zn superoxide dismutase in vascular cells: changes during cell cylcing and exposure to hypeoxia,” Am. J. Physiol. 264:L365-L375, American Physiological Association (Apr. 1993). |
Lee, C.C. et al., “Generation of cDNA Probes Directed by Amino Acid Sequence: Cloning of Urate Oxidase,” Science 239:1288-1291, American Association for the Advancement of Science (1988). |
Matsuyama, T. et al., “Pharmaceuticals for treatment of cerebral ischemia,” Chem. Abstracts 118:462 Abstract No. 66893e, Chemical Abstracts Service (Feb. 1993). |
Otsu, N. et al., “Recombinant superoxide dismutase, its manufacture with Escherichia coli, and its use in vivo or in vitro to improve oxygen function,” Chem. Abstracts 110:62 Abstract No. 18553g, Chemical Abstracts Service (1989). |
Parge, H.E. et al., “Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase,” Proc. Natl. Acad. Sci. USA 89:6109-6113, National Academy of Sciences (1992). |
Rosen, D.R. et al., “Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis,” Nature 362:59-62, Macmillan Publishers Ltd. (Mar. 1993). |
Sakamoto, A. et al., “Nucleotide sequences of two cDNA clones encoding different Cu/Zn-superoxide dismutases expressed in developing rice seed (Dryza sativa L.),” Plant Mol. Biol. 19:323-327, Kluwer Academic Publishers (1992). |
Suzuki, M., “Pharmaceuticals for control of transplant rejection,” Chem. Abstracts 118:456 Abstract No. 87658x, Chemical Abstracts Service (Mar. 1993). |
Ueno, H. et al., “Modified superoxide dismutase as inflammation inhibitor and others,” Chem. Abstracts 111:353 Abstract No. 129816k, Chemical Abstracts Service (1989). |
English Language Abstract of JP-4-108379, Derwent World Patents Index, WPI Accession No. 92-171645/199221. |
NCBI Entrez, GenBank Report, Accession No. AF002210, Culotta, V.C. et al. (1997). |
NCBI Entrez, GenBank Report, Accession No. AF046614, Zambrowicz, B.P. et al. (1998). |